tiprankstipranks
Lipella Pharmaceuticals, Inc. (LIPO)
OTHER OTC:LIPO
US Market

Lipella Pharmaceuticals, Inc. (LIPO) Financial Statements

108 Followers

Lipella Pharmaceuticals, Inc. Financial Overview

Lipella Pharmaceuticals, Inc.'s market cap is currently $2.31K. The company's EPS TTM is $-2.6; its P/E ratio is ―; Lipella Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Mar 23Dec 21Dec 20
Income Statement
Total Revenue$ 536.36K$ 449.62K$ 184.16K$ 259.35K$ 961.68K
Gross Profit$ -3.08M$ -2.59M$ -2.36M$ -1.20M$ -14.28K
Operating Income$ -5.08M$ -4.75M$ -2.59M$ -1.92M$ -56.86K
EBITDA$ -5.01M$ -4.61M$ -2.59M$ -1.86M$ -53.69K
Net Income$ -5.02M$ -4.62M$ -2.60M$ -1.87M$ -61.66K
Balance Sheet
Cash & Short-Term Investments$ 2.18M$ 3.29M$ 5.12M$ 1.71M$ 606.74K
Total Assets$ 2.67M$ 3.58M$ 5.95M$ 2.01M$ 955.02K
Total Debt$ 47.60K$ 136.59K$ 429.52K$ 282.96K$ 388.91K
Net Debt$ -2.14M$ -3.16M$ -4.69M$ -1.13M$ -217.82K
Total Liabilities$ 754.42K$ 432.73K$ 1.27M$ 589.34K$ 491.70K
Stockholders' Equity$ 1.92M$ 3.14M$ 4.68M$ 1.42M$ 463.32K
Cash Flow
Free Cash Flow$ -3.95M$ -3.16M$ -1.83M$ -989.27K$ -28.58K
Operating Cash Flow$ -3.95M$ -3.15M$ -1.83M$ -989.27K$ -28.58K
Investing Cash Flow$ 0.00$ -14.43K$ 300.55K$ -300.55K$ 0.00
Financing Cash Flow$ 2.84M$ 1.34M$ 5.24M$ 2.10M$ 609.31K
Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History

Lipella Pharmaceuticals, Inc. Debt to Assets

Lipella Pharmaceuticals, Inc. Cash Flow

Lipella Pharmaceuticals, Inc. Forecast EPS vs Actual EPS